nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies
|
Carreño, Juan Manuel |
|
|
4 |
8 |
p. e569 |
artikel |
2 |
Correction to Lancet Microbe 2023; 4: e632–41
|
|
|
|
4 |
8 |
p. e576 |
artikel |
3 |
Correction to Lancet Microbe 2023; 4: e470–80
|
|
|
|
4 |
8 |
p. e576 |
artikel |
4 |
Correction to Lancet Microbe 2023; published online June 9. https://doi.org/10.1016/S2666-5247(23)00101-5
|
|
|
|
4 |
8 |
p. e576 |
artikel |
5 |
Correction to Lancet Microbe 2023; published online June 19. https://doi.org/10.1016/S2666-5247(23)00106-4
|
|
|
|
4 |
8 |
p. e576 |
artikel |
6 |
Correction to Lancet Microbe 2023; published online May 1. https://doi.org/10.1016/S2666-5247(23)00118-0
|
|
|
|
4 |
8 |
p. e576 |
artikel |
7 |
Evaluating the relationship between community water and sanitation access and the global burden of antibiotic resistance: an ecological study
|
Fuhrmeister, Erica R |
|
|
4 |
8 |
p. e591-e600 |
artikel |
8 |
Evolution and dissemination of mobile colistin resistance genes: limitations and challenges in Latin American countries
|
Calero-Cáceres, William |
|
|
4 |
8 |
p. e567-e568 |
artikel |
9 |
First RSV vaccine approvals
|
Venkatesan, Priya |
|
|
4 |
8 |
p. e577 |
artikel |
10 |
First WHO/MPP mRNA Technology Transfer Programme Meeting
|
Rybicki, Edward P |
|
|
4 |
8 |
p. e564-e566 |
artikel |
11 |
Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis
|
Koopsen, Jelle |
|
|
4 |
8 |
p. e622-e631 |
artikel |
12 |
Hoping for hepatitis C elimination
|
The Lancet Microbe, |
|
|
4 |
8 |
p. e563 |
artikel |
13 |
Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial
|
Seekircher, Lisa |
|
|
4 |
8 |
p. e612-e621 |
artikel |
14 |
Inevitable issues in identifying mpox respiratory transmission
|
Lee, Byung Uk |
|
|
4 |
8 |
p. e572 |
artikel |
15 |
Inevitable issues in identifying mpox respiratory transmission – Authors' reply
|
Beeson, Amy |
|
|
4 |
8 |
p. e573 |
artikel |
16 |
Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?
|
Nelson, Kristin N |
|
|
4 |
8 |
p. e651-e656 |
artikel |
17 |
mRNA Technology Transfer Programme
|
Bisbas, Georgia |
|
|
4 |
8 |
p. e578 |
artikel |
18 |
Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets
|
Tickner, Jacob A |
|
|
4 |
8 |
p. e574 |
artikel |
19 |
Neisseria gonorrhoeae ciprofloxacin susceptibility testing and gyrA targets – Authors' reply
|
Rubin, Daniel H F |
|
|
4 |
8 |
p. e575 |
artikel |
20 |
Paenibacillus spp infection among infants with postinfectious hydrocephalus in Uganda: an observational case-control study
|
Morton, Sarah U |
|
|
4 |
8 |
p. e601-e611 |
artikel |
21 |
Tachykinins and the potential causal factors for post-COVID-19 condition
|
Janket, Sok-Ja |
|
|
4 |
8 |
p. e642-e650 |
artikel |
22 |
The SARS-CoV-2 furin cleavage site: natural selection or smoking gun?
|
Lubinski, Bailey |
|
|
4 |
8 |
p. e570 |
artikel |
23 |
Trends of the environmental spread of mcr genes in Latin America
|
Furlan, João Pedro Rueda |
|
|
4 |
8 |
p. e571 |
artikel |
24 |
Viral and antibody dynamics of acute infection with SARS-CoV-2 omicron variant (B.1.1.529): a prospective cohort study from Shenzhen, China
|
Yang, Yang |
|
|
4 |
8 |
p. e632-e641 |
artikel |
25 |
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study
|
Zhou, Jie |
|
|
4 |
8 |
p. e579-e590 |
artikel |